Cytoreductive surgery is a specialised cancer treatment that aims to remove all visible tumour deposits from the abdominal cavity as part of a comprehensive oncology treatment plan. At Sparsh Hospital, we offer advanced Cytoreductive Surgery in Bangalore through an experienced team of surgical oncologists supported by multidisciplinary cancer specialists who work together to deliver personalised, evidence-based care.
Every patient undergoes a detailed evaluation to determine whether Cytoreductive Surgery is the most appropriate treatment option. Depending on the diagnosis and clinical findings, surgery may be combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for selected patients to improve disease control. Our goal is to achieve maximum tumour removal while preserving organ function whenever possible. If you have been diagnosed with abdominal or peritoneal cancer, early consultation with our surgical oncology team can help identify the most suitable treatment approach.
Cytoreductive Surgery may be considered for carefully selected patients whose cancer has spread within the abdominal cavity but remains suitable for surgical removal. The procedure is not appropriate for every patient, and careful evaluation is essential before recommending treatment.
Eligibility depends on several factors, including the type of cancer, the extent and location of tumour deposits, overall health, nutritional status, and whether complete or near-complete tumour removal is considered achievable. The patient’s ability to tolerate major surgery is also carefully assessed.
At Sparsh Hospital, every case is reviewed by a multidisciplinary tumour board. This collaborative approach ensures that Cytoreductive Surgery is recommended only when it offers the greatest potential benefit as part of an individualised cancer treatment plan.
Successful outcomes begin with careful planning before the Cytoreductive Surgery Procedure. At Sparsh Hospital, every patient undergoes a comprehensive evaluation to determine whether surgery is appropriate and to optimise treatment planning.
The assessment includes detailed imaging studies such as contrast-enhanced CT scans and, where indicated, MRI or PET-CT to evaluate tumour distribution and disease burden. Blood investigations, nutritional assessment, cardiac evaluation, anaesthetic fitness, and other preoperative tests are also performed to assess the patient’s overall condition.
Each case is discussed by a multidisciplinary tumour board comprising surgical oncologists, medical oncologists, radiologists, pathologists, anaesthesiologists, and other specialists. Careful patient selection helps maximise the safety and effectiveness of the Cytoreductive Surgery Procedure while supporting the best possible long-term outcomes.
The goal of Cytoreductive Surgery is to remove all visible tumour deposits within the abdominal cavity while preserving healthy organs and maintaining normal function whenever possible. The extent of surgery varies with the location and spread of the disease, and every procedure is tailored to the patient’s individual condition.
Our experienced surgical oncology team carefully plans each operation using advanced imaging and multidisciplinary input to ensure the safest and most effective approach. Depending on the disease, multiple abdominal organs or affected tissue surfaces may require treatment during the same procedure.
The surgeon systematically removes visible tumour deposits from the affected abdominal lining and involved organs wherever appropriate. The aim is to achieve maximal tumour clearance while preserving organ function whenever clinically safe.
Some patients require collaboration between surgical oncologists and other specialists, including gastrointestinal, hepatobiliary, gynaecological, or urological surgeons, depending on the organs involved. This coordinated approach helps ensure comprehensive cancer treatment during a single operation whenever feasible.
For selected patients, Cytoreductive Surgery may be combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Following tumour removal, warmed chemotherapy is circulated within the abdominal cavity to help destroy microscopic cancer cells that may remain after surgery. Suitability for HIPEC is determined through comprehensive clinical evaluation and multidisciplinary discussion.
Recovery after Cytoreductive Surgery requires close monitoring and coordinated postoperative care. Immediately after surgery, patients are observed in a specialised recovery unit or intensive care unit (ICU), depending on the complexity of the procedure and their overall condition.
Pain management, nutritional support, fluid balance, and infection prevention are carefully managed to promote healing. As recovery progresses, patients are encouraged to gradually increase physical activity under medical supervision, with rehabilitation tailored to their individual needs. Regular follow-up appointments with the oncology team help monitor recovery, review pathology findings, and determine whether additional cancer treatment is required as part of the long-term care plan.
For carefully selected patients, Cytoreductive Surgery can play an important role in controlling abdominal cancers by removing visible tumour deposits. When combined with appropriate multidisciplinary cancer care, the procedure may help improve disease control, reduce tumour burden, and support better long-term outcomes.
The potential benefits vary depending on the type of cancer, extent of disease, overall health, and completeness of tumour removal. Careful patient selection and treatment planning are essential to maximise the benefits while minimising surgical risks. Every patient receives an individualised treatment approach based on their specific clinical condition.
Sparsh Hospital offers advanced Cytoreductive Surgery in Bangalore through a multidisciplinary team of experienced surgical oncologists, medical oncologists, anaesthesiologists, intensivists, radiologists, pathologists, and specialised nursing professionals. Every patient benefits from coordinated cancer care designed around their individual diagnosis and treatment goals.
Our multidisciplinary tumour board carefully evaluates each case to determine the most appropriate treatment strategy. Equipped with advanced operating theatres, modern imaging facilities, intensive postoperative care, and comprehensive rehabilitation services, Sparsh Hospital provides seamless care from diagnosis through recovery. Personalised treatment planning, evidence-based surgical expertise, and continuous oncology follow-up help ensure patients receive comprehensive care at every stage of their treatment journey.
Sparsh Hospital offers consultation and Cytoreductive Surgery in Bangalore through its specialised Surgical Oncology services at select centres where the procedure is available. Patients are encouraged to schedule a consultation with our surgical oncology team to determine their eligibility and receive a personalised treatment plan based on their diagnosis and overall health.
Cytoreductive Surgery is an advanced cancer operation that removes visible tumour deposits from the abdominal cavity. It is performed as part of a comprehensive cancer treatment plan for selected patients and may sometimes be combined with HIPEC when clinically appropriate.
Patients may be considered for Cytoreductive Surgery based on the type of cancer, the extent of abdominal disease, overall health, nutritional status, and the feasibility of complete or near-complete tumour removal. Final eligibility is determined after multidisciplinary evaluation.
Yes, for selected patients, Cytoreductive Surgery may be combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). The decision depends on the cancer type, disease distribution, and multidisciplinary assessment to determine whether HIPEC is likely to provide additional benefit.
The duration of a Cytoreductive Surgery Procedure varies depending on the extent of disease and the complexity of tumour removal. In many cases, the operation may take several hours, as multiple abdominal areas may require careful surgical treatment.
Recovery varies from patient to patient depending on the extent of surgery and overall health. Hospitalisation may last several days to a few weeks, followed by gradual rehabilitation, nutritional support, and regular follow-up with the oncology team to monitor recovery.
Like any major operation, Cytoreductive Surgery carries risks such as bleeding, infection, blood clots, delayed bowel recovery, and complications related to anaesthesia. These risks are carefully evaluated before surgery, and patients are closely monitored throughout recovery.
You should consult a surgical oncologist if you have been diagnosed with abdominal cancer, recurrent abdominal tumours, or have been advised that Cytoreductive Surgery may be an appropriate treatment option. Early specialist evaluation helps determine the most suitable treatment approach and improve overall outcomes.
Unlock the door to exceptional healthcare, book an appointment with SPARSH Hospital and let your journey to wellness begin.
Copyright © 2026 SPARSH Hospital, A Unit of Shiva & Shiva Orthopaedic Hospital Pvt Ltd.
Live Chat
